NOCTURNA THERAPEUTICS S.L.
A Healthtech startup included in the Barcelona & Catalonia Startup Hub
NOCTURNA TX
NoctuRNA has developed a cutting-edge platform for rapidly generating circRNA molecules that effectively target and disrupt RNA secondary structures crucial in the development of several diseases. In under 2 months, we identify target RNA structures, design, and produce circRNAs using our own protocol. Efficacy has been validated in-vitro against SARS-Cov2, Hepatitis C and West Nile Virus. They've also demonstrated efficacy reducing the aberrant pathogenic mRNA related to Steinert Disease.
Industries & Technologies
Industries:
Healthtech
Technologies:
Biotechnology,
AI & Big Data
Other fields:
Deeptech
Financial data
Funding stage:
Founded: 2022
Employees:
Other information
Business model:
Other types of licence
Target:
Business
Spinoff participants:
University (UPF)
Other startups near startup NOCTURNA TX
similar companies
Collaborators of Barcelona & Catalonia Startup Hub.
We teamed up with business associations, universities and startup incubators to create the Barcelona & Catalonia Startup Hub.